Pulmonology

 
FDA Approval of Dupilumab for Uncontrolled COPD will Change the Treatment Landscape: Interview with Surya Bhatt, MD, MSPH
September 27, 2024

Surya Bhatt, MD, MSPH, is coprincipal investigator for the 2 pivotal phase 3 clinical trials that supported today's landmark FDA approval of dupilumab for COPD.

Dupilumab Becomes First Biologic Approved in the US as Targeted Therapy for Adults with COPD
September 27, 2024

Dupilumab represents the first new treatment approach for uncontrolled COPD in more than a decade and reduced disease exacerbations by 34% in clinical trials.

ACIP Highlights Evidence Supporting Recommendation for PCV21 Vaccine for Adults
September 20, 2024

New report includes data on the safety and immunogenicity of the recently-approved PCV21 vaccine.

Roflumilast Associated with Increase in 5-Year Mortality Risk in Patients with COPD
September 06, 2024

In a large study of patients with COPD, a small increase in 5-year all-cause mortality risk was observed among those using roflumilast.

Pfizer Reports Topline Data for Abrysvo Against RSV in Younger High-Risk Adults
August 12, 2024

RSVPreF induced strong neutralizing responses in immunocompromised adults aged 18 years and older in substudy B of the ongoing phase 3 MONET clinical trial.

10 States with the Lowest COVID-19 Vaccination Rates
August 12, 2024

Wyoming, Louisiana, and Oklahoma have the lowest percentage of population with shots in arms based on state population. Is your state among the other 7?

ACIP Recommendations for RSV Vaccines in Older Adults: Update August 2024
August 08, 2024

The Advisory Committee on Immunization Practices' revisions prioritize vulnerable older adults and those at higher risk of severe infection.

ME/CFS Rates No Different After COVID-19 Infection than After Other Acute Infection-Like Illnesses
July 24, 2024

The rate of ME/CFS was similar (3% to 4%) at 3 through 12 months for study participants who tested positive and negative for COVID-19.

Respiratory Virus Vaccines: AAFP Board Chair on Patient Eligibility, How to Combat Misinformation this Season
July 19, 2024

Encouraging patients to reach out with questions may lead more to roll up their sleeves this season, Tochi Iroku-Malize, MD, told Patient Care.

Long COVID Risk Declined Over the Pandemic and Vaccination was Key, But Risk Remains
July 18, 2024

Ziyad Al-Aly, MD, and colleagues link 70% of the drop in cases to vaccine availability but caution the risk for long COVID remains significant.